Jon Faiz Kayyem - Net Worth and Insider Trading

Jon Faiz Kayyem Net Worth

The estimated net worth of Jon Faiz Kayyem is at least $137 Million dollars as of 2024-03-28. Jon Faiz Kayyem is the Director of Inhibrx Inc and owns about 3,274,301 shares of Inhibrx Inc (INBX) stock worth over $115 Million. Jon Faiz Kayyem is the SVP, Research & Development of GenMark Diagnostics Inc and owns about 911,515 shares of GenMark Diagnostics Inc (GNMK) stock worth over $22 Million. Jon Faiz Kayyem is also the Director of Biodesix Inc and owns about 173,913 shares of Biodesix Inc (BDSX) stock worth over $248,696. Details can be seen in Jon Faiz Kayyem's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jon Faiz Kayyem has not made any transactions after 2023-01-23 and currently still holds the listed stock(s).

Transaction Summary of Jon Faiz Kayyem

To

Jon Faiz Kayyem Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jon Faiz Kayyem owns 4 companies in total, including Inhibrx Inc () , GenMark Diagnostics Inc () , and Aeolus Pharmaceuticals Inc () among others .

Click here to see the complete history of Jon Faiz Kayyem’s form 4 insider trades.

Insider Ownership Summary of Jon Faiz Kayyem

Ticker Comapny Transaction Date Type of Owner
Inhibrx Inc 2023-01-23 director & 10 percent owner
GenMark Diagnostics Inc 2018-02-02 SVP & Research & Development
Aeolus Pharmaceuticals Inc 2006-06-05 10 percent owner
Biodesix Inc 2023-08-03 director

Jon Faiz Kayyem Latest Holdings Summary

Jon Faiz Kayyem currently owns a total of 3 stocks. Among these stocks, Jon Faiz Kayyem owns 3,274,301 shares of Inhibrx Inc (INBX) as of January 23, 2023, with a value of $115 Million and a weighting of 83.84%. Jon Faiz Kayyem owns 911,515 shares of GenMark Diagnostics Inc (GNMK) as of February 2, 2018, with a value of $22 Million and a weighting of 15.98%. Jon Faiz Kayyem also owns 173,913 shares of Biodesix Inc (BDSX) as of November 21, 2022, with a value of $248,696 and a weighting of 0.18%.

Latest Holdings of Jon Faiz Kayyem

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INBX Inhibrx Inc 2023-01-23 3,274,301 35.12 114,993,451
GNMK GenMark Diagnostics Inc 2018-02-02 911,515 24.04 21,912,821
BDSX Biodesix Inc 2022-11-21 173,913 1.43 248,696

Holding Weightings of Jon Faiz Kayyem


Jon Faiz Kayyem Form 4 Trading Tracker

According to the SEC Form 4 filings, Jon Faiz Kayyem has made a total of 4 transactions in Inhibrx Inc (INBX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Inhibrx Inc is the sale of 9,500 shares on January 23, 2023, which brought Jon Faiz Kayyem around $239,970.

According to the SEC Form 4 filings, Jon Faiz Kayyem has made a total of 0 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years. The most-recent trade in GenMark Diagnostics Inc is the sale of 148 shares on February 2, 2018, which brought Jon Faiz Kayyem around $759.

According to the SEC Form 4 filings, Jon Faiz Kayyem has made a total of 1 transactions in Biodesix Inc (BDSX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biodesix Inc is the acquisition of 173,913 shares on November 21, 2022, which cost Jon Faiz Kayyem around $200,000.

Insider Trading History of Jon Faiz Kayyem

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jon Faiz Kayyem Trading Performance

GuruFocus tracks the stock performance after each of Jon Faiz Kayyem's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon Faiz Kayyem is 43.73%. GuruFocus also compares Jon Faiz Kayyem's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon Faiz Kayyem within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jon Faiz Kayyem's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jon Faiz Kayyem

Average Relative Return

31.36%

Average relative return per transaction

Outperforming Transactions

75%

3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 12.57 43.73 18.25 31.36 32.5 35.88
Relative Return to S&P 500(%) 12.96 44.31 12.71 16.87 18.95 20.54

Jon Faiz Kayyem Ownership Network

Ownership Network List of Jon Faiz Kayyem

No Data

Ownership Network Relation of Jon Faiz Kayyem


Jon Faiz Kayyem Owned Company Details

What does Inhibrx Inc do?

Who are the key executives at Inhibrx Inc?

Jon Faiz Kayyem is the director & 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include 10 percent owner Ole Andreas Halvorsen , 10 percent owner Viking Global Opportunities Parent Gp Llc , and 10 percent owner Rose Sharon Shabet .

Inhibrx Inc () Insider Trades Summary

Over the past 18 months, Jon Faiz Kayyem made 4 insider transaction in Inhibrx Inc () with a net sale of 38,000. Other recent insider transactions involving Inhibrx Inc () include a net sale of 200,000 shares made by Brendan P. Eckelman , a net sale of 104,060 shares made by Mark Lappe , and a net purchase of 1,844,960 shares made by Viking Global Investors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 342,060 shares of Inhibrx Inc () were sold and 1,844,960 shares were bought by its insiders, resulting in a net purchase of 1,502,900 shares.

Inhibrx Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibrx Inc Insider Transactions

No Available Data

Jon Faiz Kayyem Mailing Address

Above is the net worth, insider trading, and ownership report for Jon Faiz Kayyem. You might contact Jon Faiz Kayyem via mailing address: 5964 La Place Court, Carlsbad Ca 92008.

Discussions on Jon Faiz Kayyem

No discussions yet.